TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06152640

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep transcranial magnetic stimulation
Description: Neuronavigation: The coil is positioned 4cm in front of the scalp point and foot motor cortex, corresponding to the ACC. The Brainways H7 coil with fluid cooling is used to obtain a greater depth of stimulation, up to about 6 cm below the cortex.~dTMS intervention: The intervention targets are at the left and right ACC, once per day, for 28 days. A total of 28 treatments are given. Stimulation mode: stimulation frequency 1Hz, stimulation intensity 100% RMT, number of pulses 150, sequence interval 20s, total 6 trials, 900 pulses.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham deep transcranial magnetic stimulation
Description: Neuronavigation: The sham coil is positioned 4 cm in front of the scalp point and foot motor cortex, corresponding to the ACC.~Sham dTMS intervention: The intervention targets are at the left and right ACC (The sham coil has the same parameters as real dTMS and generating the same noise as real coils, but without the magnetic field), once per day, for 28 days. A total of 28 treatments are given.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Basic treatment
Description: According to national and international guidelines for the treatment of eating disorders, the basic treatment for patients is nutritional therapy, that is, regular and quantitative dietary treatment, with three regular meals followed by a snack meal 2 hours after the regular meal. Both groups received the same nutritional treatment.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Basic treatment
Description: According to national and international guidelines for the treatment of eating disorders, the basic treatment for patients is nutritional therapy, that is, regular and quantitative dietary treatment, with three regular meals followed by a snack meal 2 hours after the regular meal. Both groups received the same nutritional treatment.
Study: NCT04761042

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WAYA-Wilderness
Description: The wilderness intervention includes challenging tasks in order to help participants' overcome and master new physical and psychological challenges in an unknown environment, with the idea to support self-efficacy, self-esteem, and ability to recover from adversity. The program is designed to encourage participants to connect with nature as to experience gratitude for the richness of the natural world, a sense of calmness and trust upon spending time in nature, and to be more physically active in nature.~Elements previously described Participants will continue in a three-month program at home (on-line supported) after the initial 8-days in order to empower participants to incorporate elements of the onsite wilderness program into their daily life. An individualized a plan for activities will be developed together with the participant.~After three months, there will be a re-visit with follow up on outcome measures and reconnection.

Intervention type: OTHER
Group type: OTHER
Intervention: WAYA-Holiday
Description: An attention control group (information in Detailed description)
Study: NCT05551286

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A rehabilition programme for young adult cancer survivors
Description: The programme consists of 22 sessions focusing on; 1) everyday life (energy conservation, cognitive challenges, fatigue); 2) Physical activity; 3) psychological issues; 4) work and study d; 5) sexuality and relationship; 7) rights and finance, and 8) goal setting. The sessions include both education, workshops, and engagement in different activities and will be delivered by a multidisciplinary team.
Study: NCT05408624

Intervention type: PROCEDURE
Intervention: ultrasound transvaginal drainage
Description: Ultrasound-guided transvaginal drainage of TOA by a puncture under simple sedation or analgesia with/or under general anesthesia

Intervention type: PROCEDURE
Intervention: ultrasound transvaginal drainage
Description: Ultrasound-guided transvaginal drainage of TOA by a puncture under simple sedation or analgesia with/or under general anesthesia

Intervention type: PROCEDURE
Intervention: laparoscopy
Description: Laparoscopy for drainage of TOA under general anesthesia
Study: NCT05210582

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afamelanotide
Description: Patients will receive afamelanotide over a three-month period, with an additional three-month follow up.
Study: NCT05790798

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: occupational therapy-based instrumental daily living activities intervention
Description: Occupational therapy-based instrumental activities of daily living intervention were applied to 9 people with disabilities in the intervention group, with sessions consisting of 45 minutes twice a week (totally 8 weeks/16 sessions). While the activity intervention program was being created for the intervention group, the problem areas in the ADL and IADL determined by the evaluations made before the intervention were identified. Ten occupation kits including 2 ADLs (dressing and feeding nutrition), and 8 IADLs (laundry, meal preparation, light cleaning, paperwork, use of technology, lifting and carrying, fine motor and gross motor leisure groups) were used as interventions. Various materials (jar, shirt, spoon, teapot, play dough, stapler, plastic bag, sponge, etc.) were prepared to be used in each occupation kit and to simulate daily activities.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quite recreation activity
Description: For the control group, information about the scope, duration and requirements of the research was shared throughout the process. During this period, reading activities continued. The final evaluation of all participants was made at the end of the 8th week of the study and the study was completed.
Study: NCT05742932

Intervention type: DEVICE
Intervention: Trauma surgery using Global D's implants.
Description: Major or minor participants who will be treated by an trauma surgery with ORTRAUTEK® or MINITEK/MICROTEK® implant(s).
Study: NCT04811924

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Application of 0.02% MMC over 60 seconds post corneal crosslinking.
Description: Topical application of 0.02% MMC on the surface of the cornea post CXL. The surface of the eye is washed thoroughly with Balanced Salt Solution (BSS) over 1 minute after MMC application.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Corneal crosslinking without the application of 0.02% MMC
Description: Topical application of placebo on the surface of the cornea post CXL. The surface of the eye is washed thoroughly with Balanced Salt Solution (BSS) over 1 minute after placebo application.
Study: NCT05055700

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile app with prenatal genetic testing information
Description: In the intervention group, participants will be asked to download, register, and review a mobile app on their own mobile phones before their appointment with maternal-fetal medicine specialists. This mobile app includes prenatal genetic testing information about amniocentesis, chorionic villus sampling, nuchal translucency screening, cell-free DNA, triple/quad/penta screening, anatomy ultrasound, and carrier screening.
Study: NCT05491135

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HMB002
Description: The solution containing microbeads will be infused manually into the peritoneal cavity under ultrasound guidance, with usually a 50ml syringe, as a single infusion or several infusions, to achieve in excess of 25 million hepatocytes per kilogram of the body weight.
Study: NCT06552143

Intervention type: OTHER
Group type: OTHER
Intervention: Stone needle therapy follows the Belt channel
Description: Stone needle therapy follows the Belt channel involves the use of stones by the intervener to follow the path of the Belt channel by pushing and rubbing the abdomen of patients with postpartum diastasis rectus abdominis.

Intervention type: OTHER
Group type: OTHER
Intervention: Stone needle therapy follows the Belt channel
Description: Stone needle therapy follows the Belt channel involves the use of stones by the intervener to follow the path of the Belt channel by pushing and rubbing the abdomen of patients with postpartum diastasis rectus abdominis.
Study: NCT06457516

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Mirror Therapy
Description: A mirror is used to create a reflective illusion of an affected limb in order to trick the brain into thinking movement has occurred without pain, or to create positive visual feedback of a limb movement. It involves placing the affected limb behind a mirror.

Intervention type: OTHER
Group type: OTHER
Intervention: Music Therapy
Description: Music therapy, an allied health profession, the clinical and evidence-based use of music interventions to accomplish individualized goals
Study: NCT04785144

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273.351
Description: Lipid nanoparticle (LNP) dispersion containing an mRNA that encodes for the pre fusion stabilized spike protein of the B.1.351 variant SARS-CoV-2 strain. mRNA-1273.351 consists of an mRNA Drug Substance that is manufactured into LNPs composed of the proprietary ionizable lipid, SM-102, and 3 commercially available lipids, cholesterol, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), and PEG2000 DMG.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273.351
Description: Lipid nanoparticle (LNP) dispersion containing an mRNA that encodes for the pre fusion stabilized spike protein of the B.1.351 variant SARS-CoV-2 strain. mRNA-1273.351 consists of an mRNA Drug Substance that is manufactured into LNPs composed of the proprietary ionizable lipid, SM-102, and 3 commercially available lipids, cholesterol, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), and PEG2000 DMG.
Study: NCT06378606

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive therapy
Description: intervention : group A: recive computer cognitive traing by rehacom system and omega 3 supplement .~group B: recive smart phone cognitive application and omega 3 supplement . group c recive omega 3 supplement only.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive therapy
Description: intervention : group A: recive computer cognitive traing by rehacom system and omega 3 supplement .~group B: recive smart phone cognitive application and omega 3 supplement . group c recive omega 3 supplement only.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: cognitive therapy
Description: intervention : group A: recive computer cognitive traing by rehacom system and omega 3 supplement .~group B: recive smart phone cognitive application and omega 3 supplement . group c recive omega 3 supplement only.
Study: NCT05164783

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Sanacoach Parkinson (SCP)
Description: A web-based monitoring tool for patients with PD, using questionnaires. It includes nine parts: 1) A 89-question, quarterly questionnaire about PD-symptoms. 2) Questionnaire responses are converted to scores on 16 PD-related domains. Both the current score and the score's change compared to the previous questionnaire are visible. 3) An interim evaluation is sent after 6 weeks with questions on any domains where a patient indicated problems. 4) A medication monitor can be initialized by the treating physician to evaluate the effect of a therapeutic change. 5) A consultation preparation module allows patients to indicate which topics they want to discuss during an outpatient visit. 6) Patients can ask for 'calling advise' if they are unsure whether to contact their physician. 7) Patients and healthcare providers can send each other text messages. 8) Interactive learning modules about PD. 9) Annual evaluation regarding patient satisfaction, self-management and healthcare consumption.
Study: NCT05379673

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen Gas for Inhalation
Description: Oxyhemoglobin saturation (SpO2) higher than 96% vs SpO2 between 90% and 94%.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oxygen Gas for Inhalation
Description: Oxyhemoglobin saturation (SpO2) higher than 96% vs SpO2 between 90% and 94%.
Study: NCT04823975

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Insurance Education Program (HIEP)
Description: \[See arm/group description\]
Study: NCT05055050

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UGN-201
Description: Intravesical 200 mg /50 ml x 1 dose
Study: NCT06621004

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patients will receive propranolol 1-2 mg.
Description: Patients will receive propranolol 1-2 mg. prepared in a 10 ml syringe (100 ug/ml).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patients will receive propranolol 1-2 mg.
Description: Patients will receive propranolol 1-2 mg. prepared in a 10 ml syringe (100 ug/ml).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patient receives magnesium sulphate
Description: Magnesium sulphate 10%: 1g ampoule (10ml), will be prepared in a syringe pump to be given at a rate of 40 ml/hr . Another syringe of 10 ml 0.9% sodium chloride will be prepared to be given in group (P).
Study: NCT06600126

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping Skills Training
Description: The Coping Skills Training arm will consist of 12 weekly 30-minute sessions via videoconferencing or phone. A trained research staff member will deliver sessions that focus on building coping skills for patients with COPD, such as progressive relaxation training, pleasant activity scheduling, and building communication skills. Caregivers will also participate, learning how to support the patient in using these skills. Participants will complete assignments between sessions to reinforce their learning. Additionally, participants will receive a Coping Skills Training workbook.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COPD Education
Description: The COPD Education arm will consist of 12 weekly 10-minute sessions via videoconferencing or phone. A trained research staff member will provide scripted general support and encouragement without using specific psychoeducational techniques. Caregivers will also participate. Additionally, participants will receive a COPD Education workbook with material from The COPD Foundation, which is also available on the Foundation's website. This program augments usual care, providing an attention control for comparison.
Study: NCT06625632

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antiemetic Drug
Description: All participants in the two groups will receive antiemetic drugs (ondansetron 4 mg) every 12 hours, for 5 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antiemetic Drug
Description: All participants in the two groups will receive antiemetic drugs (ondansetron 4 mg) every 12 hours, for 5 days.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin B6
Description: All participants in the two groups will receive vitamin B6 (50 mg), once daily, for 5 days.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin B6
Description: All participants in the two groups will receive vitamin B6 (50 mg), once daily, for 5 days.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home care advice
Description: All participants in both groups will be advised to eat small portions of food, drink plenty of liquids, and avoid fatty and fried foods. Additionally, they should steer clear of highly spiced foods, foods and beverages with strong odors, caffeine, and consume neither very hot nor very cold foods and liquids.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home care advice
Description: All participants in both groups will be advised to eat small portions of food, drink plenty of liquids, and avoid fatty and fried foods. Additionally, they should steer clear of highly spiced foods, foods and beverages with strong odors, caffeine, and consume neither very hot nor very cold foods and liquids.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: It will be applied for all participants in the experimental group only for 5 days. The participant will be asked to stand in erect position, her hands beside her body then applying the kinesiotape from origin (from top to bottom where the stomach is placed on the abdominal region) to insertion (alongside the gastric curvature) with tension 25% for 5 days.
Study: NCT06628557

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Mandala Art Therapy on Anxiety and Pain in Patients
Description: The Effect of Mandala Art Therapy on Anxiety and Pain in Patients

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Mandala Art Therapy on Anxiety and Pain in Patients
Description: The Effect of Mandala Art Therapy on Anxiety and Pain in Patients
Study: NCT06633939

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Behavioral Treatment
Description: The theoretical framework for the Move \&amp; Eat 2 Live intervention is guided by the health belief model (HBM), socioecological model (SEM) and motivational interviewing (MI) approach. Tailoring to the target community will include a standard cultural adaptation that will replace curriculum content and examples with Native American relevant foods, physical activities, and representation in materials. For this study, the intervention will be piloted in the target population and will include the first 5 sessions of the original 12-session program.
Study: NCT06634134

Intervention type: BEHAVIORAL
Intervention: Adjusting training advice
Description: Based on discomfort related to the menstrual cycle the female cyclist can choose to adjust the suggested training.
Study: NCT06633315

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low dos dexmedetomidine
Description: received dexmedetomidine 2.5 μ g/kg nasal drops

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high dos dexmedetomidine
Description: received dexmedetomidine 3 μ g/kg nasal drops

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dexmedetomidine and esketamine
Description: received dexmedetomidine 2 μ g/kg nasal drops plus ketamine 0.5 mg/kg nasal drops
Study: NCT05699486

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PDNO
Description: PDNO consists of propylene glycol (1,2-propanediol, PD) chemically combined with NO (to be donated). The drug substance is formulated as an inherent mixture of 4 structure analogues. The mixture consists of an equilibrium of the 2 regioisomers 1-(nitrosooxy) propan-2-ol and 2-(nitrosooxy) propan-1-ol. In addition, each regioisomer is a racemic mixture.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium chloride (placebo)
Description: Placebo (NaCl, commercially available dilution solution for parenteral use, 9 mg/mL)
Study: NCT05177718

Intervention type: DRUG
Group type: OTHER
Intervention: Natalizumab 300 MG in 15 ML Injection
Description: Disease modifying agent
Study: NCT05955729

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI)
Description: 24-question sleep quality assessment scale, a score \> 5 indicates poor sleep quality
Study: NCT04771923

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Topical instillation of tranexamic acid up to 3x. If bleeding is not controlled patients crossover to adrenaline.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adrenaline
Description: Topical instillation of adrenaline up to 3x. If bleeding is not controlled patients crossover to tranexamic acid.
Study: NCT05955729

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Epworth questionnaire
Description: 8-question sleepiness assessment scale, a score above 10 indicates excessive sleepiness

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epworth questionnaire
Description: 8-question sleepiness assessment scale, a score above 10 indicates excessive sleepiness

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The Karolinska Sleepiness Scale
Description: The Karolinska Sleepiness Scale measures daytime sleepiness on a 9-point scale, based on 5 states and 4 intermediate states that are not verbally indicated.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Karolinska Sleepiness Scale
Description: The Karolinska Sleepiness Scale measures daytime sleepiness on a 9-point scale, based on 5 states and 4 intermediate states that are not verbally indicated.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Actimeter
Description: An actimeter will be worn on the non-dominant wrist, uninterrupted day and night, for 7 consecutive days.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Actimeter
Description: An actimeter will be worn on the non-dominant wrist, uninterrupted day and night, for 7 consecutive days.
Study: NCT04632108

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASKB589 Injection
Description: ASKB589 Injection with dose escalation stage of 0.3mg/kg up to10mg/kg,as well as dose expansion stage with recommended dose level from dose escalation stage.
Study: NCT06180070

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen/ Paracetamol tablets
Description: 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen/ Paracetamol tablets
Description: 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol